Eric H. Yang, MD

Eric H. Yang, MD
Email: Ehyang@mednet.ucla.edu

UCLA Cardio-Oncology Program · Cardio-Oncology · Cancer Treatment Associated Cardiotoxicity

In 2016, the UCLA Cardio-oncology Program officially made its debut, actively managing patients undergoing cancer treatments, providing risk stratification, evaluating for and treating cardiotoxicity, as well as providing long term cardiotoxicity surveillance for cancer survivors.

This is a multidisciplinary collaboration across multiple specialties within the Divisions of Cardiovascular Disease and Hematolog/Oncology at UCLA in promoting awareness, research projects in looking at the effects of malignancies and cardiotoxic treatments on both the adult and pediatric populations. I have been the primary cardiology consultant for the UCLA-LIVESTRONG Survivorship Center of Excellence since 2012 and also conducting research projects in looking at the application of multimodality imaging such as echocardiography, cardiac magnetic resonance and cardiac computed tomography in evaluating for short and long-term clinical and subclinical evidence of cardiotoxicity from cancer treatments; this includes, but is not limited to chemotherapy, novel targeted therapies, and radiotherapy.

Publications

Vascular Toxicities of Cancer Therapies: The Old and The New—An Evolving Avenue. Joerg Herrmann, Eric H Yang, Cezar Iliescu, Cindy Grines, Mehmet Cilingiroglu, Kostantinos Charitakis, Abdul Hakeem, Konstantinos Toutouzas, Massoud A Lessar, Konstantinos Marmagkiolis. Circulation 2016;133(13): 1272-89. doi:10.1161/CIRCULATIONAHA.115.018347.

Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week. Salim S Hayek, Sarju Ganatra, Carrie Lenneman, Marielle Scherrer-Crosbie, Monika Leja, Daniel J Lenihan, Eric Yang, Thomas D Ryan, Jennifer Liu, Joseph Carver, Negareh Mousavi, Rupal O’Quinn, Anita Arnold, Jose Banchs, Ana Barac, Bonnie Ky. J Am Coll Cardiol 2019;73(17):2226-35.

Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives. Sarju Ganatra, Joseph R Carver, Salim S Hayek, Monika J Leja, Daniel J Lenihan, Carrie Lennenman, Negaresh Mousavi, Jae H Park, Miguel A Perales, Thomas D Ryan, Marielle Scherrer-Crosbie, Richard M Steingart, Eric H Yang, Vlad Zaha, Ana Barac, Jennifer E Liu. J Am Coll Cardiol 2019;74:3153-63.

UCLA Cardio-Oncology Program Faculty

Olujimi Ajijola, MD, PhD
Gentian Lluri, MD, PhD
Megan Kamath, MD
Gabriel Vorobiof, MD
Melkon Hacobian, MD
Megha Agarwal, MD
Boris Arbit, MD
Nidhi Thareja, MD